Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Novalis LifeSciences

Investor type Venture Capital
Founders Marijn Dekkers


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 2.60
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Agriculture
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Novalis LifeSciences:
Typical Co-investors
Novalis LifeSciences is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Novalis LifeSciences:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atlantic Innovation Fund -
Core Associates Florida, Jupiter, United States
Lacuna LLC Boulder, Colorado, United States
Penghua Fund China, Guangdong, Shenzhen
QinetiQ Cardigan, Ceredigion, United Kingdom
RyderVentures Florida, Miami, United States
Suhehui China, Shanghai
SVG Media Gurgaon, Haryana, India
Uchida Yoko Japan, Tokyo
Wardenclyffe Partners Delaware, Dover, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$85M03 Jun 2022 Cambridge, Massachusetts, United States

Sherlock Biosciences

Health Care
Health Diagnostics
Life Science
$80M08 Mar 2022 Cambridge, Massachusetts, United States

Ori Biotech

Industrial Automation
$100M18 Jan 2022 London, England, United Kingdom


Health Care
Health Diagnostics
21 Dec 2021 Rotterdam, South Holland, Netherlands


Service Industry
$116M14 Sep 2021 Raleigh, North Carolina, United States

Modality.AI, Inc

Artificial Intelligence
Health Care
Machine Learning
Natural Language Processing
$2M30 Jul 2021 San Francisco, California, United States


$37M07 Apr 2021 Cambridge, Massachusetts, United States

Cerevel Therapeutics

$320M29 Jul 2020 Boston, Massachusetts, United States

Enko Chem

$45M26 Jun 2020 Woburn, Massachusetts, United States
AgBiome Raises $116 Million Led By Blue Horizon and Novalis LifeSciences

– AgBiome raised $116m in an oversubscribed Series D round of funding.
– The round was co-led by Blue Horizon and Novalis LifeSciences and included multiple new and existing investors.
– The company will use the capital to expand more rapidly its product portfolio, scale its scientific and commercial teams, and continue to build its global presence and partnerships.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Novalis LifeSciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: